OSTEOPATHIC MEDICINE SUPPORTIVE CARE IN PEDIATRIC

J
Jenny Belsky, DO

Primary Investigator

Overview

By embedding OMM into targeted chemotherapy regimens, this study intends to demonstrate the positive impact of an innovative integrated treatment plan for patients who routinely experience these side effects as a consequence of their therapy.  

Description

Successful completion of the outlined aims will advance our understanding of OMM interventions in the pediatric oncology field and begin to establish baseline medication needs for constipation and pain. This increased understanding will directly impact pediatric oncology supportive care and has the potential to lead to a reduction in pharmacologic supportive care interventions.

Eligibility

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    chemotherapy
  • Age: Between 2 Years - 10 Years
  • Gender: All

Inclusion Criteria:
  • 1) patients aged >2 years to < 10 years as study tools for assessment of constipation, pain and quality of life have been validated for this age group,
  • 2) must have a confirmed oncology diagnosis of ALL, actively receiving chemotherapy with standard risk therapy entering consolidation with planned interim maintenance phases of treatment
  • 3) caregiver must have the ability to understand and the willingness to sign a written informed consent document in English, due to survey availability in English only.
Exclusion Criteria:
  • 1) Patients must not have had a surgical procedure other than biopsy, lumbar puncture, bone marrow biopsy/harvest, or central line placement within 3 weeks of study enrollment
  • 2) Prior malignancy or pre-existing condition including but not limited to inflammatory bowel disease, diabetes, chronic pain syndromes, chronic neuropathic pain, trisomy 21 and additional genetic conditions are excluded due to confounding variables
  • 3) Patients with a significant illness that is not covered by the exclusion criteria or that is expected to interfere with the action of study treatment are not eligible.

Updated on 02 May 2024. Study ID: 11059, PHO-IIR-OSTEOPATHICMEDICINE
Please visit our main page to search for other studies you may be interested in. If you need help finding a study or have any questions, please contact us at inhealth@iu.edu

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center